Literature DB >> 2118634

Kinetics and pattern of degradation of thyrotropin-releasing hormone (TRH) in human plasma.

J Møss1, H Bundgaard.   

Abstract

The kinetics and mechanism of degradation of the tripeptide TRH (pGlu-His-Pro-NH2) and its various primary and secondary degradation products (TRH-OH, His-Pro-NH2, and His-Pro) have been determined in human plasma at 37 degrees C. The rates of degradation of both TRH and TRH-OH (pGlu-His-Pro) showed mixed zero-order and first-order kinetics. At low substrate concentrations first-order kinetics occurred, with TRH and TRH-OH degradation half-lives of 9.4 and 27 min, respectively. The initial step in the plasma-catalyzed degradation of TRH is due to hydrolysis of the pGlu-His bond by the TRH-specific pyroglutamyl aminopeptidase serum enzyme, resulting in the exclusive formation of histidyl-proline amide (His-Pro-NH2). Using specific HPLC methods the major degradation route (67%) of this dipeptide in human plasma was hydrolysis of the peptide bond to yield His and Pro-NH2, whereas deamidation to yield His-Pro accounted for 29% of the total degradation. A minor pathway (less than or equal to 4%) was spontaneous cyclization to yield cyclo(His-Pro). Both His-Pro-NH2 and His-Pro degraded by first-order kinetics and faster than TRH, with half-lives of 5.3 and 2.2 min, respectively, in 80% plasma.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2118634     DOI: 10.1023/a:1015875824238

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  46 in total

1.  Characterization of a thyroliberin-degrading serum enzyme catalyzing the hydrolysis of thyroliberin at the pyroglutamyl-histidine bond.

Authors:  K Bauer; P Nowak
Journal:  Eur J Biochem       Date:  1979-09

2.  Inhibition of prolactin secretion by histidyl-proline-diketopiperazine.

Authors:  K Bauer; K J Gräf; A Faivre-Bauman; S Beier; A Tixier-Vidal; H Kleinkauf
Journal:  Nature       Date:  1978-07-13       Impact factor: 49.962

3.  Characterization of a pyroglutamate aminopeptidase from rat serum that degrades thyrotropin-releasing hormone.

Authors:  W L Taylor; J E Dixon
Journal:  J Biol Chem       Date:  1978-10-10       Impact factor: 5.157

4.  A comparison of thyrotropin-releasing hormone with analogs: influence of disposition upon pharmacology.

Authors:  M Hichens
Journal:  Drug Metab Rev       Date:  1983       Impact factor: 4.518

5.  TRH degradation rates vary widely between different animal species.

Authors:  D Brewster; K Waltham
Journal:  Biochem Pharmacol       Date:  1981-03-15       Impact factor: 5.858

6.  An evaluation of the role of a pyroglutamyl peptidase, a post-proline cleaving enzyme and a post-proline dipeptidyl amino peptidase, each purified from the soluble fraction of guinea-pig brain, in the degradation of thyroliberin in vitro.

Authors:  P Browne; G O'Cuinn
Journal:  Eur J Biochem       Date:  1983-12-01

7.  Serum inactivation of the immunological and biological activity of thyrotropin releasing hormone (TRH).

Authors:  R Bassiri; R D Utiger
Journal:  Endocrinology       Date:  1972-09       Impact factor: 4.736

8.  Inactivation of thyrotrophin releasing hormone by human and rat serum.

Authors:  T J Visser; W Klootwijk; R Docter; G Hennemann
Journal:  Acta Endocrinol (Copenh)       Date:  1977-11

Review 9.  Prolyl endopeptidase.

Authors:  S Wilk
Journal:  Life Sci       Date:  1983-11-28       Impact factor: 5.037

10.  Thyrotropin-releasing hormone metabolism in visceral organ homogenates of the rat.

Authors:  M Safran; C F Wu; C H Emerson
Journal:  Endocrinology       Date:  1982-06       Impact factor: 4.736

View more
  3 in total

1.  Pyroglutamyl peptidase type I from Trypanosoma brucei: a new virulence factor from African trypanosomes that de-blocks regulatory peptides in the plasma of infected hosts.

Authors:  Rory E Morty; Patrick Bulau; Roger Pellé; Sherwin Wilk; Koji Abe
Journal:  Biochem J       Date:  2006-03-15       Impact factor: 3.857

2.  Prodrugs of peptides. 6. Bioreversible derivatives of thyrotropin-releasing hormone (TRH) with increased lipophilicity and resistance to cleavage by the TRH-specific serum enzyme.

Authors:  H Bundgaard; J Møss
Journal:  Pharm Res       Date:  1990-09       Impact factor: 4.200

3.  Transepithelial transport and metabolism of thyrotropin-releasing hormone (TRH) in monolayers of a human intestinal cell line (Caco-2): evidence for an active transport component?

Authors:  E Walter; T Kissel
Journal:  Pharm Res       Date:  1994-11       Impact factor: 4.200

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.